Elisabetta Augusta Renzoni
Elisabetta Augusta Renzoni publishes mostly in Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Physiology, on topics such as Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Systemic Sclerosis and Related Diseases and Chronic Obstructive Pulmonary Disease (COPD) Research.
- World rank
- #26,716 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #1,991 of 367,258
- Works
- 326
- Citations
- 16k
- Citations per work
- 49.8
What does Elisabetta Augusta Renzoni research?
Elisabetta Augusta Renzoni's work is mostly in Medicine (80%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences25979.6%
- Medicine25979.6%
- Everything else5516.9%
- Life Sciences113.5%
- 1Pulmonary and Respiratory Medicine53% of their works
- 2Pathology and Forensic Medicine10% of their works
- 3Physiology8% of their works
- 4Epidemiology6% of their works
- 5Molecular Biology4% of their works
- 6Oncology2% of their works
Research topics
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Systemic Sclerosis and Related Diseases
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Sarcoidosis and Beryllium Toxicity Research
- Medical Imaging and Pathology Studies
- Inflammatory Myopathies and Dermatomyositis
- Pulmonary Hypertension Research and Treatments
- Occupational and environmental lung diseases
Which keywords describe Elisabetta Augusta Renzoni's research?
The keywords of their largest research topics: Fibrosis, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, TGF-ß, Autoantibodies, Treatment, Endothelial Dysfunction and Diagnosis.
- BAP1 mutations
- Pulmonary Hypertension
- Dermatomyositis
- Pulmonary Alveolar Microlithiasis
- Cardiac
- COPD
- Pulmonary Involvement
- Diagnosis
- Treatment
- TGF-ß
- Interstitial Lung Disease
- Fibrosis
- Idiopathic Pulmonary Fibrosis
- Autoantibodies
- Endothelial Dysfunction
- Management
- Systemic Sclerosis
- spirometry
- Sarcoidosis
- Pulmonary Sclerosing Hemangioma
- Inflammatory Myopathies
- Right Heart Assessment
- Malignant Pleural Mesothelioma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Fibrosis3402 topics
- Interstitial Lung Disease2942 topics
- Idiopathic Pulmonary Fibrosis2511 topic
- TGF-ß2511 topic
- Autoantibodies1322 topics
- Treatment1322 topics
- Endothelial Dysfunction1272 topics
- Diagnosis1122 topics
- Management1122 topics
- Pulmonary Involvement891 topic
- Systemic Sclerosis891 topic
- COPD601 topic
- spirometry601 topic
- Cardiac521 topic
- Sarcoidosis521 topic
- Pulmonary Alveolar Microlithiasis441 topic
- Pulmonary Sclerosing Hemangioma441 topic
- Dermatomyositis431 topic
- Inflammatory Myopathies431 topic
- Pulmonary Hypertension381 topic
- Right Heart Assessment381 topic
- BAP1 mutations201 topic
- Malignant Pleural Mesothelioma201 topic
Where does Elisabetta Augusta Renzoni work?
Elisabetta Augusta Renzoni's main affiliation in the publication record is Royal Brompton Hospital, United Kingdom.
How many publications and citations does Elisabetta Augusta Renzoni have?
OpenAlex counts 326 works and 16,241 citations for Elisabetta Augusta Renzoni, an h-index of 70, ranking #26,716 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Elisabetta Augusta Renzoni. Posts are plain text and can be reported.